Literature DB >> 7068635

Effects of methotrexate on ribonucleotide pools in growing and in growth-arrested tumor cells and antagonism by RNA synthesis inhibitors.

E Kaminskas.   

Abstract

We examined the mechanism of ribonucleotide pool changes in methotrexate-treated Ehrlich ascites tumor cells in culture. In exponentially growing cells, methotrexate inhibited ATP and GTP formation and stimulated UTP and CTP formation by the de novo pathways. Over the following 4 h, ATP and GTP decreased and UTP and CTP increased. During this period RNA synthesis rates decreased by 30 to 40%. Inhibitors of nucleolar RNA synthesis (actinomycin D, doxorubicin, or cycloheximide), but not of DNA synthesis (cytosine arabinoside), prevented ATP and GTP depletion. These results suggest that ATP and GTP were depleted in methotrexate-treated cells because the shift-down of RNA synthesis occurred more slowly than the inhibition of ATP and GTP supply. UTP and CTP pools increased because of increased de novo synthesis and because of decreased consumption in RNA synthesis. Ribonucleoside triphosphates were increased and their syntheses by de novo pathways were inhibited in cells treated with RNA synthesis inhibitors. ATP decreased slightly and GTP remained unchanged in growth-arrested cells treated with methotrexate. In growth-arrested cells, de novo purine nucleotide synthesis was inhibited less and RNA synthesis rates were lower than in growing cells.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7068635

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  4 in total

Review 1.  Targeting Ribosome Biogenesis in Cancer: Lessons Learned and Way Forward.

Authors:  Asimina Zisi; Jiri Bartek; Mikael S Lindström
Journal:  Cancers (Basel)       Date:  2022-04-24       Impact factor: 6.575

Review 2.  Genetic instability as a consequence of inappropriate entry into and progression through S-phase.

Authors:  A Almasan; S P Linke; T G Paulson; L C Huang; G M Wahl
Journal:  Cancer Metastasis Rev       Date:  1995-03       Impact factor: 9.264

3.  Accumulation of DNA strand breaks and methotrexate cytotoxicity.

Authors:  J C Li; E Kaminskas
Journal:  Proc Natl Acad Sci U S A       Date:  1984-09       Impact factor: 11.205

4.  Bioluminescent, Nonlytic, Real-Time Cell Viability Assay and Use in Inhibitor Screening.

Authors:  Sarah J Duellman; Wenhui Zhou; Poncho Meisenheimer; Gediminas Vidugiris; James J Cali; Prson Gautam; Krister Wennerberg; Jolanta Vidugiriene
Journal:  Assay Drug Dev Technol       Date:  2015-09-18       Impact factor: 1.738

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.